Shanghai Argo Biopharmaceutical Co., Ltd.
EA Policies for Single Patient

At this time, Argo Biopharma does not provide access to our investigational therapies outside of clinical trials. We believe that participation in well-controlled clinical studies is the most appropriate method for evaluating the safety and efficacy of our investigational medicines and for ensuring the highest standards of patient protection.